The Influence of a HAART regimen on the expression of HIV-associated Kaposi sarcoma.
Paparizos
Vassilios A
VA
Kyriakis
Kyriakos P
KP
Kourkounti
Sofia
S
Leuow
Kirsten
K
Daskalakis
Evangelos
E
Katsambas
Andreas
A
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D012008:Recurrence; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D012514:Sarcoma, Kaposi / Q000175:diagnosis*
D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors